Back
IDEAYA Biosciences Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
48
IDYA
IDEAYA Biosciences
Last Price:
37.43
Seasonality Move:
20.52%
Sell
20
NBY
NovaBay Pharmaceuticals
Last Price:
0.48
Seasonality Move:
-14.79%
Sell
48
IDEAYA Biosciences (IDYA)
is a Sell
Is IDEAYA Biosciences a Buy, Sell or Hold?
- The current IDEAYA Biosciences [IDYA] share price is $37.46. The Score for IDYA is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- IDYA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
20
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.47. The Score for NBY is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
IDYA Stock Price Chart
What is IDEAYA Biosciences's stock price today?
-
The IDEAYA Biosciences share price today is $37.46
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IDYA is experiencing buying pressure, which is a positive indicator for future bullish movement.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.47
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing selling pressure, which indicates risk of future bearish movement.
IDYA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.67 | Sell |
Relative Strength Index (14 RSI): | 46.83 | Sell |
Chaikin Money Flow: | 375903 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (36.91 - 39.33) | Sell |
Bollinger Bands (100): | (36.63 - 41.33) | Sell |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.13 | Sell |
Relative Strength Index (14 RSI): | 31.78 | Sell |
Chaikin Money Flow: | -80501 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.45 - 0.53) | Sell |
Bollinger Bands (100): | (0.7 - 3.44) | Sell |
IDYA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 36.87 | Buy |
20-day SMA: | 38.22 | Sell |
50-day SMA: | 39.16 | Sell |
200-day SMA: | 39.7 | Sell |
8-day EMA: | 37.05 | Buy |
20-day EMA: | 37.8 | Sell |
50-day EMA: | 38.5 | Sell |
200-day EMA: | 37.38 | Buy |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.47 | Buy |
20-day SMA: | 0.5 | Sell |
50-day SMA: | 0.99 | Sell |
200-day SMA: | 3.99 | Sell |
8-day EMA: | 0.47 | Buy |
20-day EMA: | 0.54 | Sell |
50-day EMA: | 1.03 | Sell |
200-day EMA: | 8.66 | Sell |
IDEAYA Biosciences Earnings Growth & IDYA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.05 per share, a decrease this year of $0.59 per share, and a decrease next year of $0.27 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $13.87 per share, an increase next quarter of $0.05 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.
IDEAYA Biosciences Technical Analysis
Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |